Journal
CLINICAL ENDOCRINOLOGY
Volume 80, Issue 6, Pages 773-781Publisher
WILEY
DOI: 10.1111/cen.12446
Keywords
-
Categories
Ask authors/readers for more resources
Insulin-like growth factor-II (IGF-II) is a widely expressed 7 center dot 5kDa mitogenic peptide hormone. Although it is abundant in serum, understanding of its physiological role is limited compared with that of IGF-I. IGF-II regulates foetal development and differentiation, but its role in adults is less well understood. Evidence suggests roles in a number of tissues including skeletal muscle, adipose tissue, bone and ovary. Altered IGF-II expression has been observed in metabolic conditions, notably obesity, diabetes and the polycystic ovary syndrome. This article summarizes what is known about the actions of IGF-II and its dysregulation in metabolic and endocrine diseases. The possible causes and consequences of dysregulation are discussed along with the implications for diagnostic tests and future research.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available